IDA Review

8/10/2019 IDA Review

1/39

5 Ea aa a aaa a

UK Naa S C (UK NSC)

V: 2

B

2012

T UK NSC a M a NHS a UK a a a . I

a a 3 a . C a aaa a

://.../a a a

://.../

1.2, 2010


2/39

UK NSC Ea R

Pa 2

I

I

I a a a a . T a a a

a.

Ia a a a 24 , aa a 9 a 18

a a a a (ID). T

a a a aa a aa a a .

I a a . I aaa (IDA) ID

a , a a a (H) a

a aa a a a aa a.

IDA a a aa a a . I aa,

a a , a aa .C

S IDA a 5 a a UK . T a

a 2006. N a a

a a a a a a a

a a a.

T 2006 2011 a

IDA a 5 a a aa UK Naa S C (NSC)

a aa a, a aa a a

(Naa S C 2003).

T a a a aaa 2006, 2006

US Pa S Ta F (USPSTF) IDA 6

12 a aa. T a a

aa IDA aa a

6 12 .1T a a a a IDA UK,

a 1996, 1999 a 2001 a A La S

Pa a C (ALSPAC) a aa. T a H

a a a 8 , 12 a 18 a a

a a 6 1992 B a D Ha

A aa.

I a a a US IDA.

T Aa Aa Paa (AAP) a a 2010

a aaa a aa 12 a

a H a a a a aa ID/IDA. 2F

a a (13 a a), aa a a a

a ID/IDA.2T US C Da C a P (CDC)

IDA a a .3T USPSTF a

a Aa Aa Fa Pa (AAFP) IDA

a a 6 12 a a a a a '

.4


3/39


4/39

UK NSC Ea R

Pa 4

A C C

T a a aaa a ://.../a .

1.

I 2006 a aa IDA a

a. Pa IDA a C 2.

T USPSTF a 2006 a a a

.4

IDA a aa a a, ,

a a a a a a . I AAP a

2010 a IDA .2T a a a

a a a IDA a a a

a, . T a2001 Ca a a

a IDA ( 2009)5a a

2007 aa MCa a A.6

T 2007 aa MCa a A a a a a

a aa a a ID a

aa .6A , a aa

IDA a a aa a a

2 a

a IDA a a , a a a.

H, MCa a A a a IDA a a

a a a a a

aaa.6T a a:

5 (, ,

, , )

, , ,

. , ,

.


5/39

UK NSC Ea R

Pa 5

T Ca Ra a a 12 23 a a

19 a. I a a , a a H 12.0/L a

a a . Aaa a a

IDA. C a a a a a ID . G a a a H

12.0/L a aa a. C ID a a H

10.0/L a aa a a, H>10.0/L a ID

a a 3 a. A 5 a a,

ID a 12 23 a a a a. D a

a, ID a 12 23 a

a a a, a, a aa, a

a . M ID

a a aa a a a

.7I , a a a aa a aa. F

a a a a aa a aa: a a, a a , aa a a

aa .7

M a a a a a a,

a a 5 a a 1114 a a. C ID a

a a . A aa a a

, a.8A a a

, , a a, a a , a

, a, IQ a a . T a

a a , , a a a . 8

A 19 a a, a a ID

aaa , , a

a, a a a aa a.9

Ba aa a a aa (a; ; ;

a a a; a a; a a a; a

; a; a; IQ; a a

; aa ; a ;

a; aa IQ), a a aa a

a .

T a a a . I

aa a

a ID a 12 23 a a a

a a 8 9 a 19 a a, a a . H,

aa a, a 10 a 25

.10S a a a Ha F Fa I,

aa a a a, a a . G a

a a aa.10

T a a C . O a a RCT a

a a a a

10. H, a a a a a a (a 6

12 a) IDA a a a a,

. G a


6/39

UK NSC Ea R

Pa 6

a aa a a a ; aa

.11T a IDA a 6, 12 a 18 a

a a a. A aa a. C a IDA

aa a aa .12I a a a aa.

Sa a a US . N a

a a . Sa a

aa a . Ia IDA a a

a a .1315Ba a, a a a

aa a a a a aa a, a aa

. O a a a 9 a

a 12 . A a (9 ) IDA a aa a

( a a a a a ). A

a a IDA a H 105/L a a .

H, a 12 13 .16Maa aa a

a a a a , aa ,

a, a , a a a a, , a,

a a a a, a . Ia aa

a a , , , a, a a .16IDA a

a a a a a a a 9 a 12 .17I

, a a a a a a aa a

a a aa .17Ia aa a,

, , aa a, a a ; a a aa

aa aa a, aa a, aa a, aa

, aa a, aa a a, a, a

H Oa Ma ER, L E S aSa S a. E a a a , a a

a a a a a a. I a a

IDA a a a a a aa a, a

a.18Ba a, , , aa a,

a, a a a a aa. T a aa

a a a aa.18Fa, a

a (ERP) ' a a a' a a 9 a/ 12

a a . Aaa ERP a a a 9

a. T a a a 12 IDA .19T

IDA a a a a aa, a

a a a a aa a

a.19

Ca a (2010) a a aa 4

a C : a IDA a aaa a

24 ( IDA), a a IDA a a

24 ( IDA) a a aa.

C a a IDA a a a, a

a, a a, a a a aa

a a aa a 4 a a. T a a a IDA


7/39

UK NSC Ea R

Pa 7

a aa a aa.20T a a a

aa a aa. T a a a a a

a aa.

T a a a. A a

aa a a aa .

A a IDA Ia a IDA a

a a . T a a aa

a a, aaa a a (H 7/L a a >24

a ).21

O a a a a

49 IDA a 26 a a 6 a 12 a.

IDA a a a. N a a

a IDA a a . H,

a a a 15 a a.22

Sa (a a a ) a a a

IDA.2325

O a a Ta 1.


8/39

UK NSC Ea R

Pa 8

1: .

S Paa O F

Aaa a., 200826

315 a

20 IDA, 20

aaa

P

Qaa

aa

(EEG)

,

/ ,

/

.

Sa a., 200827

36 a

19 IDA, 38 a

A a aa

.

Ma a., 201028

6 24

a

25 IDA, 25

IDA

Va E a

.

Paa a., 201029

6 72

49 IDA, 100

a

P

DDSTII

aa 67.3%

aaa a15.0%

( < 0.01).

N UK a aa IDA a a

2006 . T a a a a

a H a 8, 12 a 18 a a 18 a a A

La S Pa a C (ALSPAC) 2001.30

D, a G Sa Ma D, a a 1,141

a 18 , a H aaa 942 a 8 , 835 a 12 a 810 a 18 . A a , aa

a, , , a a ,

a a aa a aa, a

a H a


9/39


10/39

UK NSC Ea R

Pa 10

IDA

T Naa Ha a Eaa S 1999 a 2002,

AAP a a a IDA a a/ a a.2

T US CDC, Ra P a C I D U

Sa,3a a a a a IDA a:

Pa a.

Ia 12 a.

Ba a a 6 a.

Fa a a.

C a 15 a a 25 , a

a.

C a a , a

.

O a ID aa/aa a aaa a,

a, a, a a a

a a a a .38

I a a . I a a

, a a a aa a a . I

fi (ID) fi aa a a a , a, a . IDA a

fi a a ID. Aaa a H

a aa a a H a a a

a a a a. ID a a aaa

a a a .2,3,39

A ID IDA, ID a a a a a IDA. H, a

IDA a ID, ID a. F a,

ID ( a H [CH]


11/39

UK NSC Ea R

Pa 11

T E S 2006 USPSTF a

, ,

. ,

.1

F , a a RCT a

UK, E a US. W .

D ,

T 2010 AAP a a ID a IDA ,

a a; , a a; a; a (13 a a).

T a , a a 1/ a a

4 aa a a a . T, a a a a a a

a a 4 6 a. P a a a

a 2/ a 12 a. T a

a a a a a 1 a, a

a a . T a 1 a 3 a a a

a 7/a. T , a

a.

I a, US CDC a :3

Ba a a a a 4 6

a . Ta a a a a a .

Ta ( , a a ) a

12 a.

Ta a a a 4 6 , a

aa a C 6 a, a a C

a a.

C a 1 5 a a 24 ,

a a .

A 2002 aa a a ,

. 38I a a UK aa

1 a a,41a NHS a , a a a

a.42NICE CG37 Paa a PH11 Maa a C N

a a a

a .43,44A 2008 Ea S Paa Ga,

Ha, a N (ESPGHAN) a a a

(.. a a a a a a a)

17 a 26 . T a a a

a a a 12 .45


12/39

UK NSC Ea R

Pa 12

T a a, a, a aa a a

a a a EU a.

46,47

Ia a aa a a 0.3 a 1.3

100a. Fa a a a 0.45 a 2

100a. F a 0.6 a 2 100a (0.9

2.5 100a a aa a a).46A

3 100a a a a a a a

, a .47P a a a a a

.

A a aa a . T

a a , , a a

, a aaa a a a a a IDA a.

A 2011 Ca a a a (MNP) a a 2 a a. I

a MNP aaa a ID, a

a a a. H, a a

Aa, Aa a Caa, aaa a

a .48

A a a a a a

a, , a, a . I

RCT, a (CT) a a

(CBA). E 12

a Ha D I 2009. M a a

a a aaa a. H,a , , a ,

a a a .49

A a a a a a

. W a a , a a a

ID a a aaa.50

A a (SR) a RCT aa a

. T a a . Aa, a a

.

A 2011 Ca a a a a a a a a

a a

a 12 a a a a a . I 33 a,

La Aa, Aa a Aa. I a a

a a a a a H a SF a, a

a aaa.51

A SR a a a a a

( a a a ) a

a aa H a


13/39

UK NSC Ea R

Pa 13

a a. H,a 25 a

.52

T 2009 US RCT a a 1 5.5 4 9 a a a a. I a

a. N a a, a a , a

a ID IDA.53,54

T E S 2006 USPSTF a:

.

( 0.05 / , 0.03 0.13; =0.21).

,

.1

A aa a a a a a a a a ID, a

a a, a a a

a a a a

. H, a ,

a a.55

Ma a a a

a . A a a a

a a a a

a 2006 a .56A 2009 a a a

4 6 a a a aa a a a

a a a a a a.53H, a a 2 a

a.53Sa 1 5.5 a a . 54. A 2008

aa a RCT a a a a 10

a Ca a a a . G

a 6 12 a a (6 a 12 ) a

a ( a a ) aa.57

P a a a a a EU .46,47T WHO a 2001

a a a a a

aaa.

58

O a a a

ID a IDA. I a , H (2010) a a aa

a a a .

H, a a a a a a

aa a a.59A a

, a a a , a a a ,

a a a a .60


14/39

UK NSC Ea R

Pa 14

E

A a a a a a

S a a a a a a a , a a, a

a a a (=0.01).41

A Caaa RCT a a , aa a a aa

a 9 a a 2

a a. T aa a a aa a

a a aa 15 18 a a ID.

B a , a a a

a a a a a a

. T a a a 16 a. I

a a a

, a .

61

Sa a a a a

a a. T a a a

aaa a a a aaa aa a a

(aa a a ).62,63A RCT S a

a a (3 a ) a a

a ID a 4 a a a aa aaa a 2 a

a.64I A 2011 Ra C Oa a Ga (RCOG) a a

a G G Pa Haa, a

aa.65T RCOG a a:

,

.

: C 3 . ,

,

. I

.

.

4. I

,

.N aa.

5. , ,

I a a, 2006 USPSTF a a

,

.4

T 2010 AAP a a a

.2T a a a a ID a IDA


15/39

UK NSC Ea R

Pa 15

a a a, a a IDA a a a H

a a, a a aaa a a a.2

E US a aa IDA a a aH H a , a WHO a a a aa

aa a SF a aa a

ID a.2,3,58

A H H aaa . T a

aaa a ID, a a IDA, a . T US

CDC a a:

(..,

)

.. .3

T a a a aaa a a a a a

a. T a Ta 2. O aaa AAP a a

a a a a ID, SF Ca (CRP),

H (CH) a. T a IDA,

H a, a a

.2T AAP a aa a

1 (TR1) aa.2A aa 2008 a a, H,

SF a, CRP a, TR a/ (ZPP) a.66

A a a a ID. H,

a a a .

40

T a aa, aaa aa a

aaa.39,40,66

S a a aa a a, a a, a

a.39,66SF a a a a; a

aaa a aa; a a a a

ID a a a.39,66,67H, SF a a

a , a a, a, a flaa.

I a a a a .68S a (TR)

a a a a a , , a

aa a a a TR a a

aa.66,69

Z (ZPP) a a a a . E

a H. Z a

a ID , a ZPP a. T

a ZPP/a a a aa a . I

a ID, .66A a

US a ZPP a (, 28%) (, 72%)

a H ( 11%, 94%) ID a .70T

a a, , a a aa

aa aa Naa Ha a N S a

ID a H a 1 5.71


16/39

UK NSC Ea R

Pa 16

CH, a aaa a, a a a a . R a

a a a , a 24 a 48

a. L H a a . I a

aa aa 210 a a a 2.9 a, aa a ID a, CH a ID a IDA

. A 26 CH a a 70% a 78% ID a a

83% a 75% IDA.68A CH


17/39


18/39


19/39

: C 5 . H H H

IDA. H, H H

, ID

, IDA. IDA ,

IDA.

. F, CH

IDA. D , ,

IDA .

6.

N a a a UK a a

IDA UK 2006 a a.

D H H .

N a 2006 a a a H

H a UK. O aa , a, H a SF a

aa a a a a ALSPAC a a a

a 1992 B a D Ha A. A 8

a, H a a a a (SD) 117 (11)/L (95% a

116 118/L) a a 72 153/L.36H a a

a 8 .36A 12 a, a H a (SD) a 118 (10)/L,

a a 18 a 117 (10)/L.37N aa a aa

H a a 12 a. A 18 a, a

aa aa a aa H a.G a H a a , a H a a U a

aa a.

C

Aaa H a a aa a a H a

a a a a a a.58T WHO H a H

aaa a a a 110/L H a 0.33% H,

a 6 59 .58T AAP a a a a 19992002

US Naa Ha a N Eaa S, aaa a a H a

a 110/L a 12 35 .2

Pa 1996 a 1999 ALSPAC B a. A8 a, a a aaa a a H

a


20/39

UK NSC Ea R

Pa 20

3: C AAC IDA AAC

H

H


21/39

UK NSC Ea R

Pa 21

4: C . A

2008.66

* AC EIA .

ID

H (H) 6 59 : 110/L

H (H) 6 59 : 0.33%

B (C) N

B H (CH) I a a


22/39

UK NSC Ea R

Pa 22

N a a aa . H,

aa a a

, ,

.75

: C 7 . IDA

.A

, . H,

IDA.

8.

N UK a .

T 2010 AAP a a H a a 11.0/L a 12

a a a a ID a SF a CRP ,

CH a . Aa, a a aaa (H 10

11/L) a a a IDA.2

T US CDC a a aaa a

a. T a (3/ a)

. A a H a 1/L H 3% a

IDA, a a a . I MCV,

(RDW) a SF a

a aaa.3

T WHO a H H aa SF, EP, TR a IDA.58

A aa 2008 a a, H, SF a, CRP a,

TR a/ ZPP a.66

: C 8 .

.

H H

, .

9. I

, ,

N aa.

10.

,

I 2006 a a USPSTF a a

. (


23/39

UK NSC Ea R

Pa 23

) ,

, .4

T 2006 USPSTF a: 3 6

, 7 10 .

..1

I a a , a a

.

.4

F , a a a a

UK, E a US. W .

I US, ID a a 3/ a a. 3,38A

a a a C, a a .38I

a a a a a , a ID/IDA

a a .3,38T a a

US a aa ( ) a a a a

a ID 18 a a a a .77

/

A aa a a a a a aa

a ID, a a.38T a a

a a a a.

A a Ca a a IDA

a .78I a RCT a a a

a a, a IDA, a a

a. Pa a, , a a

a a ,

( a H), , a ,

a a a a .

A a a a a a

a H a

25 a Fa 2006. B a a a . H,a 25 a . T

a a a

a aa H .52

A a a a a

a S a a a a

.50

A 2007 aa MCa a A6 2010 AAP a a2

a a aa IDA a


24/39

UK NSC Ea R

Pa 24

>2 a a. H, a a a 24 a ).21N

a a a 15 a a a a

a a .22

A RCT L a. (2010) a a a ,

a a,

a a a IDA a a a.11Ca

a IDA a a ( a 6 a 12 ) a a

a a a a a. Ia

IDA (a 6 a 12 ) a a a a a

a, a a a. Ia IDA

a a a a a aa

aa a a , a a a IDA

a . H, , a a


25/39

UK NSC Ea R

Pa 25

a a. T, a a a a

a a a IDA,

a a a a IDA.

Sa aa a a a a ID a a

a a ID

.79,80

T US a a a IDA a 9 , a

.1719I a, ID a a a a a

1223 Ca Ra , a a .710T

a . Sa 4a

C a IDA a aaa a 24

a a, a a a a IDA a

aa aa.20

A Ia a a a a aaa a a (H

7/L a a >24 a ).21

: C 10 . I .

IDA .

,

, .

11.

N a a a a.

12. C

T 2010 AAP a a a:

( ) ,

/

.

12

.2

H, 4984 US

a a H a.81F

ID (a 9 a), a 25% a a a

6 , a 4.4% 11.6% a ID. A UK

a a aa a, a a 16 a,

a E a a.82R, a a a aa

a a ID, a a a a (MCV)

aa, a aa. T a aa

, a . A a a aa 21%


26/39

UK NSC Ea R

Pa 26

a a aa a a/ . T

a a a (P a., 200583) a a a a

a a a 36 a Paa

E Da Caaa. Ta a 35% MCV.

C 12 .F

E , ,

ID .

13. C

.

(. D ,

), .

T 2006 USPSTF a:

,

,

.1

I a a , a a

.4

N RCT a a.

C 13 C IDA

.

14. (,

, / ) ,

N a a a a.

15.

( ,

)

T 2006 USPSTF a a a a

a a IDA. C, , a a a

a a a . T a a a a

a aa a a .1

N a a a IDA

a a.


27/39

UK NSC Ea R

Pa 27

16. ( ,

, , )

(. ). A

/

O a US ID a

a a. I a a a

ID 9 a 12 a CH, H a.84I , a

ID a a 9%. S a a CH a H ID

a (CH


28/39

UK NSC Ea R

Pa 28

20. E , ,

,

N a a a ,

a a a, a , a a.

21.

, ,

. D

N a a a a.

22. I

N aa.


29/39

UK NSC Ea R

Pa 29

C

I a a . I a a

, a a a aa a a . I

fi (ID) fi aa a a

a , a, a . I aaa (IDA)

ID a , a a a

a a aa a a a a

a a a a. D, aa a aa a a

a a IDA.ID, a a a

IDA, a. C a 9 a 18 a a

IDA a a a a a . A

a a

IDA a 24 a. O a a a aa ID.

IDA a a aa a a a aa

. H, aaa aa IDA a a a a

a. T aa a

a a aaa. D , IDA a a

a a .

Ra a, a ,

a a a a. H,

a a UK . T a a a a a a

.

Ha (H) aa (H) a WHO a a

US IDA. T H a 110/L a a

aaa 12 35 a US. H, a H a H a

aaa, a aaa a ID aaa

a, a a a a a a

a IDA. T a a IDA aaa , a a

IDA. S a a a a . Ma ,

H a a IDA, a a

a a .

T, a a ID a IDA , a , a a a a

a .

Oa a a ID a IDA. T a a

aa IDA . T aa a


30/39

UK NSC Ea R

Pa 30

a a a ,

a a a a a, a .

T a a a IDA

a . I a, aa a , aa a a

ID UK. T a UK .

I

T a 2006 a a aa

a aaa a 5 a a.

I

T a aa a :

.F a a aa IDA a

a aa , a . T

a IDA UK a.

. T a a a IDA a a

a aa. Qaa a aa, a

a aa a a a .

. F a . T a

aa a a UK a.

T aa a aa.

. A a aa IDA a, a a

a IDA , a

a a a a a.

. RCT a a a

. T a IDA a .


31/39

UK NSC Ea R

Pa 31

BACGD: A a a a a

aaa Naa S C a

2001 a a 2000a.

CE EACHED: M, Ea, Ca La, PINFO, Ca, W S

a C R a Da (CRD) aaa.A a aR

Ca Ta, CaTa. a HTA aaa a

, a a .

DAE F EACH: Jaa 2000 4 Jaa 2010

EACH AEG: M O

T a a a a a a

aaa a . A a a a a a

.

1. Ia/

2. Ia, /

3. C/

4. a$2..

5. ..

6. $3..

7. a$2..

8. 1 2 3 4 5 6 79. Aa, I D/

10. (a$ aa$)..

11. $..

12. 9 10 11

13. Ma S/

14. Naa S/

15. $3..

16. $3..

17. ( )..

18. "S a S"/

19. ( )..

20. Pa Aa Ha Ca/

21. N Ta/

22. 13 14 15 16 17 18 19 20 21

23. C D/

24. Naa Maa/

25. Da Da/

26. Eaa Sa/

27. ($2 a (a a$ $

a$ a a $))..

28. ..

29. ((a a a) a a$)..


32/39

UK NSC Ea R

Pa 32

30. aa$..

31. a$..

32. I/

33. $..34. a /

35. Ta $..

36. CB Aa/

37. ($ a $)..

38. 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37

39. 8 a 12 a 22 a 38

T a a (2000 Jaa 2010).

E: T a a 1074 a M. A a a a

Ea, Ca La, CRD aaa, PINFO, Ca a W

S.

Daaa N

M 1074

Ea 1263

Ca La 215

CRD aaa 94

PINFO 37

Ca 318

W S 1889 4890

T a a aaa a.

T a aa a a a

aaa , a (). I aa,

a a:

aaa , a a a

a a a ? D a

? a ?

a a? I aa, a a a a

a? (T a)

230a a.

T a a aa 28 O 2011.


33/39

UK NSC Ea R

Pa 33

T .

Daaa N

M 230

Ea 563

Ca La 45

PINFO 20

Ca 42

W S 485

1390

A a , 963 a. T a aa

a a a a a a. 63a

a.

T, a, 293a a a

aaa .

Pa 2006 , a a a

. T a a a a a aaa a aa .

G, a a UK, E a US .

F aa a . F a a , . Aa a

aa a .

1. O Ea Pa C. S I D Aaa

C a Pa: Ua 1996 U.S. Pa Ta F R

E S, N. 40. R (MD): A Haa Ra a Qa

(US); 2006. Aaa : ://....//NBK33399/ .

2. Ba RD, G FR. Ca R Da a P I D a

ID Aa Ia a Y C (03 Ya A). Pa.2010;126(5):104051.

3. C Da C a P. Ra P a C

I D U Sa. MMWR. 1998;47(. RR3).

4. U.S.Pa S Ta F. S I D Aa I

I Sa C a Pa W. R (MD):

U.S.Pa S Ta F; 2006. Aaa :

://.a./06//. .


34/39

UK NSC Ea R

Pa 34

5. Ma S, La S, G RE. I a

a a aaa.

Ca Daaa S R. 2001;(2):CD001444.

6. MCa JC, A BN. A a aa a

a aa . A J C

N. 2007;85(4):93145.

7. Ca F, Raa AE, L B. I a a a a

5 a. J D Ba Pa. 2006;27(5):3718.

8. Sa T, ABa R, Caa A a. E a

a . H M S. 2006;25(6):82138.

9. L AF, K M, B MJ a. I a a

a 19 a: a

. N N. 2010;13(2):5470.

10. L B, J E, S JB. D a a

a: a a aa a 19 a.

A Pa A M. 2006;160(11):110813.

11. L B, S JB, Ca KM a. H I I C a Sa

Ea S ID A Ia. Pa. 2010;126(4):E884E894.

12. Pa PD, Aa CR, Ga MI a. I aa a aa

a a aa a . Pa R.2007;62(6):7159.

13. ASa R, KaaE M, Ja SW a. ID Aa Ia

a MIa Ia D F. J D Ba Pa. 2010;31(4):32632.

14. Sa T, ABa R, J Y a. I a a .

Ea H D. 2008;84(7):47985.

15. Sa T, ABa R, S J a. I aa a a a a

a . Ia Ba D. 2009;32(4):36675.

16. Ca R, Ja JL, B MJ a. I aa a a. Pa. 2010;126(2):427434.

17. L B, Ca KM, J Y a. D a

aa a a aa a. J Pa.

2008;152(5):696702.

18. L B, ASa R, Ka N a. E a a a

aa a a a. J N.

2010;140 (5):105761.


35/39

UK NSC Ea R

Pa 35

19. B MJ, W AJ, ASa R a. A a a

a a a aa. Pa.

2007;120(2):336345.

20. Ca SY, Wa L, Wa YY a. ID Aa Ia a Sa

Ea D PA C C. Pa.

2011;127(4):E927E933.

21. Ga SK, Baa D, Ma P a. Da

aa a a a a a. Ia J Pa.

2010;77(4):3759.

22. Ba SG, Aa M, Ta E a. T

/ a . C P. 2007;40(5):74154.

23. Ma JL, V G, Pa PC. Aa aa a

. Pa. 2007;120(5):10537.

24. M PA, D V C, Ha C a. S aaa a a

. A D C. 2011;96 (3):2769.

25. Kaaa FD, Ma MD, Baa LR a. I aa aa

a : a a. Pa. 2008;121 2:S146S147.

26. Aaa R, O GA, Pa Ma R a. Da CNS aa

aa a. N N. 2008;11(2):618.

27. Sa JN, L SMA, Ra SPM a. Ha a a aa

a a aa . P. 2008;20(4):25560.

28. Ma M, Waa V, Ga A a. E aa a

a . Ba D. 2010;32(3):2136.

29. Paa E, E M, G S a. P

a aa. F N B. 2010;31(3):4315.

30. S A, E A, B JC a. S a aaa? A

a a a a 8, 12, a 18 a

a 18 . A D C. 2001;84(6):4805.

31. Ha G, Saa B, Wa A a. I a a Na a

624 . Aa Paa. 2004;93(5):5928.

32. Ma C, P LA, Fa V a. Pa 12 a

11 Ea aa a a a a (EG

). Aa Paa. 2001;90(5):4928.

33. Ta A, Ma S, W ID a. Aa . I J

Pa. 2011;2011:813541.


36/39

UK NSC Ea R

Pa 36

34. D NE, Ca BG, S PB a. Pa

D . J Pa. 2010;157(6):96771.

35. B IW, A MA. I aaa a a a . A DC. 1997;76(6):54953.

36. E AM, Ha N, P C a. Ha a a

a a 8 a. A D C. 1996;74(1):369.

37. S A, E A, Ha N a. Ha a a

a 12 a 18 . ALSPAC C F S Ta. A D C.

1999;80(2):1537.

38. Kaa LA, J. P a a . A Fa Pa.

2002;66(7):121724.

39. W Ha Oaa, C Da C a P. A

a a. S E. Ga: W Ha Oaa; 2007.

Aaa :

://..//a//aaa__/97

89241596107..

40. U C, W A, A C a. S a a

. JAMA. 2005;294(8):92430.

41. Baa AC, Sa J, Ha I a. Fa a

a a S. J C N. 2011;20(1314):188794.

42. NHS C. B . [L]: Da Ha; 2010. Aaa :

://../a//a/aa.a.

43. NICE. Paa a: R aa a a a. CG37. L:

Naa I Ha a Ca E; 2006. Aaa :

://a.../aaa37.

44. NICE. I a a a a

. PH11. L: Naa I Ha a Ca

E; 2011. Aaa : ://a.../

aaaa11.

45. A C, D T, F M a. Ca F: A Ca

ESPGHAN C N. J Pa Ga N. 2008;46(1):99110.

46. T C Ea C. C D 2006/141/EC 22

D 2006 a a a a a a D

1999/21/EC. [B]: EURL; 2006. Aaa : ://

.a./LUS/LUS.?=CELEX:32006L0141:EN:NOT .


37/39


38/39

UK NSC Ea R

Pa 38

60. Ja L, R S, Taa A a. I a a

aa a. J Pa Ha O. 2010;32

(8):5858.

61. Ma JL, B CS, Ja S a. Oa

a : TARG K! Paa, a a. Pa.

2010;126(2):343350.

62. H EK, Haa ES. La a a a a:

a a aaa a. JAMA. 2007;297(11):124152.

63. MDa SJ, M P. E a a a

aa a aa . Ca Daaa S R. 2008;(2):CD004074.

64. A O, HWa L, A D a. E a a

a a aa a a a 4 : a

a a. BMJ. 2011;343:7157.

65. Ra C Oa a Ga. P a Maa

Pa Haa. G G N.52. L: Ra C

Oa a Ga; 2011. Aaa :

://.../a/aa/a

aaaaa52.

66. Za MB. M a a a. B J N. 2008;99

3:S2S9.

67. Ya Z, D KG, La B a. Ca aa a

a aa a a :

4 a. A J C N. 2008;87(6):18929.

68. Baa C, Za D, DCa J a. R a

. JAMA. 1999;281(23):222530.

69. V N, Ta T, L S a. T a a

a a a. I J La Ha.

2009;31(4):4406.

70. C R, F AM, W RJ a. Caa a a a ,

a : Paa a . Pa.

2006;118(1):22432.

71. M Z, Paaa I, C ME a. E :

a a ? A J C N.

2003;77(5):122934.


39/39

UK NSC Ea R

72. K R, G R, Laaaa L. P a

a 624 . Ma (Kaa).

2008;44(9):6737.

73. Baa C, S B, Ma J. R a (R H) a

a a. C La Haa. 2006;28(5):3038.

74. Ba J, R R, Sa MD a. Da a. La M.

2007;38(2):1039.

75. Ba R. O a aa a a .

C La S. 2008;21(4):22532.

76. W Ha Oaa. N: Ca P C, S Daa, a

Ia: Ia A Va A a I Sa Pa

aa WHO N Ga E A G (NUGAG)

M a Eaa (M&E) S . [Ga]: W Ha

Oaa; 2010. Aaa :

://..///__ME_a__

//..

77. Ca SE, Ha K, Baa GR. Ia

a a a. Pa B Ca. 2011;56 (4):6159.

78. Z X, W T. I a aa (P).

Ca Daaa S R. 2007;(2):CD006465.

79. L B, G MK. I a a . S Pa N.

2006;13(3):15865.

80. L B. I a . F N B. 2007;28(4):S560S571.

81. B PG, D SM, Ca AE a. S a

. Pa. 2006;117(2):2904.

82. Saaa DN, K S, Baa A. M a a

aa a: a a. BMC Pa. 2009;9.

83. P MV, Da BJ, M D. O 636 Paa E Da. BMC Pa.

2005;5:42.

84. Sa M, J P, U C a. A aa aa

a. J Pa. 2009;154(1):449.

IDA Review

Documents

Transcript of IDA Review